January 17, 2013

Cadence Pharmaceuticals, Inc. et al v. Fresenius Kabi USA, LLC

View recent docket activity


Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.


Coverage

  1. July 08, 2014

    Cadence Sanctioned In Generic Drug Patent Dispute

    A California magistrate judge on Tuesday sanctioned Cadence Pharmaceuticals Inc. for violating a protective order by providing Fresenius Kabi USA LLC's confidential material to counsel involved in patent prosecution amid an intellectual property battle, requiring Cadence to reimburse for costs incurred while investigating the breach.


Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS